IGC Pharma (IGC) EBT Margin Growth (5y) (2015 - 2025)
IGC Pharma (IGC) EBT Margin Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
IGC Pharma |
28.11 Mn |
27.85 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
37,220.00 |
| Jun 30, 2025 |
-16,524.00 |
| Mar 31, 2025 |
1.05 Mn |
| Dec 31, 2024 |
-43,192.00 |
| Sep 30, 2024 |
-35,200.00 |
| Jun 30, 2024 |
-79,064.00 |
| Mar 31, 2024 |
-87,576.00 |
| Dec 31, 2023 |
-265,037.00 |
| Sep 30, 2023 |
-73,635.00 |
| Jun 30, 2023 |
-33,923.00 |
| Mar 31, 2023 |
-237,742.00 |
| Dec 31, 2022 |
-60,749.00 |
| Sep 30, 2022 |
-107,955.00 |
| Jun 30, 2022 |
-49,658.00 |
| Mar 31, 2022 |
-451,784.00 |
| Dec 31, 2021 |
-164,735.00 |
| Sep 30, 2021 |
-739,396.00 |
| Jun 30, 2021 |
-219,718.00 |
| Mar 31, 2021 |
-353,877.00 |
| Dec 31, 2020 |
-210,993.00 |
